/ Print /

Tracey Walker
Seven things to know about Express Scripts’ plan to limit opioids
As President Trump declares the opioid epidemic “a national emergency,” a new opioid management program from Express Scripts will limit the number and strength of opioid drugs to first-time patients.
How Cigna reduced opioid use 12% in 12 months
Managed Healthcare Executive (MHE) recently spoke with Cigna’s Chief Medical Officer for Behavioral Health Doug Nemecek, MD, about Cigna’s efforts, outcomes, and how it plans to reach its goal
New challenges, opportunities in autoimmune disease treatment
Allegheny Health Network’s Susan Manzi, MD, MPH, discusses the healthcare needs of patients with lupus and other autoimmune disorders.
Six barriers to prescribing PCSK9 inhibitors
A National Lipid Association survey has interesting findings on the prescription approval process for PCSK9 inhibitors.
Five ways to combat growing polypharmacy among children
One expert believes managed care executives are key to a necessary paradigm shift in pediatric polypharmacy.
Three barriers to artificial intelligence adoption
Artificial intelligence will play a major role in healthcare digital transformation. Here’s how to adopt more AI-supported activities in your digital transformation initiative.
Four solutions to value-based care challenges
An annual study commissioned by Quest Diagnostics and Inovalon reveals interesting findings to keep value-based care moving forward.
Four key trends in healthcare innovation
A Klick Health survey shows there’s opportunities for healthcare innovation and technology to play larger role in patient’s lives.
Top 10 states with the worst drug problems
WalletHub released a study comparing 50 states and the District in terms of 15 key metrics, ranging from arrest and overdose rates to opioid prescriptions and meth-lab incidents per capita.
Multiple myeloma treatment advances: What health execs should know
It has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.